Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 58Recruiting 17Terminated 12Unknown 8Active not recruiting 7Available 3Withdrawn 2Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 240Breast 13Thoracic 10Gastrointestinal 7Head & Neck 6Gynecologic 4CNS 3Sarcoma 2Endocrine 2Other solid neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1Dermatologic 1

Conditions

Sarcoma 60Gliosarcoma 19Glioblastoma 19Osteosarcoma 15Lymphoma 14Central Nervous System Neoplasms 13Dendritic Cell Sarcoma, Interdigitating 11Rhabdomyosarcoma 10Oligodendroglioma 10Neuroblastoma 10Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Brain Neoplasms 10Bone Neoplasms 10Astrocytoma 10Recurrence 9Breast Neoplasms 9Sarcoma, Ewing 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Liposarcoma 8Glioma 8Burkitt Lymphoma 8Wilms Tumor 7Neoplasm Metastasis 7Melanoma 7Hodgkin Disease 7Gastrointestinal Stromal Tumors 7Ovarian Neoplasms 6Medulloblastoma 6

Interventions

Taxes 2trastuzumab biosimilar HLX02 1pertuzumab 1palbociclib 1olaparib 1niraparib 1eribulin 1entrectinib 1cobimetinib 1atezolizumab 1alectinib 1Vinorelbine 1Vemurafenib 1Trastuzumab 1Specimen Handling 1Polymerase Chain Reaction 1Paclitaxel 1PF-05280014 1Ontruzant 1Ogivri 1Letrozole 1Irinotecan 1Immunoglobulin G 1HhAntag691 1Gene Expression Profiling 1Fulvestrant 1Disulfides 1Carboplatin 1Capecitabine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × Sarcoma × Clear all
NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Withdrawn
BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT00499291 2023-05-25

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Eastern Cooperative Oncology Group

Phase NA Withdrawn
BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Teratoma, Testicular, Teratoma, Ovarian, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Stomach Neoplasms, Teratoma, Testicular Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡